RT Journal Article SR Electronic T1 Treatment of orbital myositis with adalimumab (Humira). JF The Journal of Rheumatology JO J Rheumatol FD The Journal of Rheumatology SP 1374 OP 1375 VO 32 IS 7 A1 Alexa B Adams A1 Michael Kazim A1 Thomas J A Lehman YR 2005 UL http://www.jrheum.org/content/32/7/1374.abstract AB Adalimumab is a fully humanized IgG1 monoclonal antibody to tumor necrosis factor-a. We describe 2 patients (17 and 13 years of age) with refractory, steroid-dependent, recurrent nonspecific orbital myositis not controlled with standard immunosuppressive medications. Both improved with adalimumab treatment, allowing reduction in corticosteroid dosage without disease flare.